Combining antidepressants
- PMID: 25642112
- PMCID: PMC4311111
- DOI: 10.11919/j.issn.1002-0829.214177
Combining antidepressants
Abstract
Treatment-resistant depression is a common problem encountered by psychiatrists. These patients are often difficult to treat effectively. Strategies for addressing patients with treatment-resistant depression include changing medications, adding another antidepressant (antidepressant polypharmacy), and augmenting treatment with a non-antidepressant.
难治性抑郁症是精神科医生面临的一个普遍问 题。这些患者往往难以有效治疗。治疗难治性抑郁症 患者的策略包括换药、增加另一种抗抑郁药(抗抑郁 药联合治疗)以及抗抑郁药以外的增效治疗。
Keywords: Treatment-resistant depression; antidepressant polypharmacy; augmentation; switching antidepressants.
Similar articles
-
Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.World J Psychiatry. 2015 Sep 22;5(3):330-41. doi: 10.5498/wjp.v5.i3.330. World J Psychiatry. 2015. PMID: 26425446 Free PMC article.
-
Medication options in the treatment of treatment-resistant depression.Aust N Z J Psychiatry. 2004 Apr;38(4):219-25. doi: 10.1080/j.1440-1614.2004.01335.x. Aust N Z J Psychiatry. 2004. PMID: 15038800 Review.
-
Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy.Shanghai Arch Psychiatry. 2014 Dec;26(6):360-2. doi: 10.11919/j.issn.1002-0829.214182. Shanghai Arch Psychiatry. 2014. PMID: 25642111 Free PMC article.
-
Using adjunctive treatments when first-line antidepressants fail.J Clin Psychiatry. 2012 Jan;73(1):e01. doi: 10.4088/JCP.10126tx4c. J Clin Psychiatry. 2012. PMID: 22316580
-
Pharmacological Treatments for Patients with Treatment-Resistant Depression.Pharmaceuticals (Basel). 2020 Jun 4;13(6):116. doi: 10.3390/ph13060116. Pharmaceuticals (Basel). 2020. PMID: 32512768 Free PMC article. Review.
Cited by
-
5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.Curr Neuropharmacol. 2021;19(9):1545-1559. doi: 10.2174/1570159X18666201015155816. Curr Neuropharmacol. 2021. PMID: 33059577 Free PMC article.
-
Exercise improves depression through positive modulation of brain-derived neurotrophic factor (BDNF). A review based on 100 manuscripts over 20 years.Front Physiol. 2023 Mar 8;14:1102526. doi: 10.3389/fphys.2023.1102526. eCollection 2023. Front Physiol. 2023. PMID: 36969600 Free PMC article.
-
Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review.Biomedicines. 2023 Feb 14;11(2):550. doi: 10.3390/biomedicines11020550. Biomedicines. 2023. PMID: 36831086 Free PMC article. Review.
-
Neuronal life or death linked to depression treatment: the interplay between drugs and their stress-related outcomes relate to single or combined drug therapies.Apoptosis. 2019 Oct;24(9-10):773-784. doi: 10.1007/s10495-019-01557-5. Apoptosis. 2019. PMID: 31278507 Free PMC article.
-
The Novel Imipramine-Magnesium Complex Exerts Antidepressant-like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test.Molecules. 2025 Jan 23;30(3):519. doi: 10.3390/molecules30030519. Molecules. 2025. PMID: 39942624 Free PMC article.
References
-
- Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. - PubMed
-
- Thase ME, Rush AJ. When at first you don’t succeed: sequential strategies for anti-depressant nonresponders. J Clin Psychiatry. 1997;58(Suppl13):23–29. - PubMed
-
- Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, et al. Prospective,long-term,multi-centerstudyof the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry. 2006;67:688–695. - PubMed
-
- Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry. 1999;60:256–259. - PubMed
LinkOut - more resources
Full Text Sources